In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Understanding the Biological Basis of Pediatric Cancer

July 19, 2016

Understanding the Biological Basis of Pediatric Cancer
Advances in genomic medicine indicate that pediatric cancers may be quite different from their adult counterparts. Hear from experts on why this might be and what scientists are doing to understand it better.

Many pediatric cancers do not harbor the same targetable mutations seen in adult tumors, making it imperative that we understand the reasons behind these differences. Following up on the 2016 Sohn Conference, "Pediatric Cancer in a Post-genomic World," presented by The Sohn Conference Foundation and the New York Academy of Sciences, this podcast gives listeners a glimpse into where research and treatment are today and where they are headed in the future.